Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: Interpretation of substrate hydroxylation regioselectivity from docking studies.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbagen.2015.03.014PMID 25857771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of Cytochrome P450 Enzymes

  2015cited by this paper
• Oxidation of Endogenous N-Arachidonoylserotonin by Human Cytochrome P450 2U1*

  2014cited by this paper
• Identification of cytochrome P450s involved in the metabolism of arachidonic acid in human platelets.

  2013cited by this paper
• Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound*

  2012cited by this paper
• Debrisoquine Metabolism and CYP2D Expression in Marmoset Liver Microsomes

  2012cited by this paper
• Quantum mechanically derived AMBER‐compatible heme parameters for various states of the cytochrome P450 catalytic cycle

  2012cited by this paper
• Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.

  2012cited by this paper
• Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.

  2011cited by this paper
• Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology

  2011cited by this paper
• Structure and Dynamics of the Membrane-Bound Cytochrome P450 2C9

  2011cited by this paper
• Cytochrome P450 CYP2 genes in the common cormorant: Evolutionary relationships with 130 diapsid CYP2 clan sequences and chemical effects on their expression.

  2011cited by this paper
• Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier.

  2011cited by this paper
• Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acids hydroxylation.

  2010cited by this paper
• Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish

  2010cited by this paper
• Xenobiotic-Metabolizing Cytochromes P450 in Human White Adipose Tissue: Expression and Induction

  2010cited by this paper
• Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism

  2010cited by this paper
• Profiling the expression of cytochrome P450 in breast cancer

  2010cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase

  2009cited by this paper
• Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function

  2009cited by this paper
• Determinants of Cytochrome P450 2C8 Substrate Binding

  2008cited by this paper
• Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking

  2008cited by this paper
• Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues

  2007cited by this paper
• Unusual regioselectivity and active site topology of human cytochrome P450 2J2.

  2007cited by this paper
• MOLE: a Voronoi diagram-based explorer of molecular channels, pores, and tunnels.

  2007cited by this paper
• Selective, competitive and mechanism-based inhibitors of human cytochrome P450 2J2.

  2007cited by this paper
• The ins and outs of cytochrome P450s.

  2007cited by this paper
• Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2.

  2006cited by this paper
• MUSTANG: A multiple structural alignment algorithm

  2006cited by this paper
• Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking.

  2006cited by this paper
• 3,4-Dehydrodebrisoquine, a Novel Debrisoquine Metabolite Formed from 4-Hydroxydebrisoquine That Affects the CYP2D6 Metabolic Ratio

  2006cited by this paper
• Cytochrome P450 Profile of Colorectal Cancer: Identification of Markers of Prognosis

  2005cited by this paper
• The Amber biomolecular simulation programs

  2005cited by this paper
• Novel extrahepatic cytochrome P450s.

  2005cited by this paper
• Crystal Structure of Human Cytochrome P450 2D6*

  2005cited by this paper
• New AMBER force field parameters of heme iron for cytochrome P450s determined by quantum chemical calculations of simplified models

  2005cited by this paper
• CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes ω- and (ω-1)-Hydroxylation of Fatty Acids*

  2004cited by this paper
• MUSCLE: a multiple sequence alignment method with reduced time and space complexity

  2004cited by this paper
• Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1.

  2004cited by this paper
• CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids.

  2004cited by this paper
• Residues Glutamate 216 and Aspartate 301 Are Key Determinants of Substrate Specificity and Product Regioselectivity in Cytochrome P450 2D6*

  2003cited by this paper
• Detailed analysis of grid‐based molecular docking: A case study of CDOCKER—A CHARMm‐based MD docking algorithm

  2003cited by this paper
• Catalytic specificity of CYP2D isoforms in rat and human.

  2002cited by this paper
• Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.

  2000cited by this paper
• Enantioselectivity of debrisoquine 4-hydroxylation in Brazilian Caucasian hypertensive patients phenotyped as extensive metabolizers.

  2000cited by this paper
• Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling

  2000cited by this paper
• Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6.

  1999cited by this paper
• 1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans.

  1998cited by this paper
• Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

  1997cited by this paper
• Yeast expression of animal and plant P450s in optimized redox environments.

  1996cited by this paper
• Automated docking of flexible ligands: Applications of autodock

  1996cited by this paper
• A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.

  1996cited by this paper
• Errors in protein structures

  1996cited by this paper
• Evaluation of comparative protein modeling by MODELLER

  1995cited by this paper
• Evidence That Aspartic Acid 301 Is a Critical Substrate-Contact Residue in the Active Site of Cytochrome P450 2D6 (*)

  1995cited by this paper
• Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.

  1995cited by this paper
• Detection, delineation, measurement and display of cavities in macromolecular structures.

  1994cited by this paper
• Xenobiotic metabolism in humanized yeast: engineered yeast cells producing human NADPH-cytochrome P-450 reductase, cytochrome b5, epoxide hydrolase and P-450s.

  1993cited by this paper
• Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation.

  1993cited by this paper
• Urethane protected derivatives of 1-guanylpyrazole for the mild and efficient preparation of guanidines

  1993cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide.

  1993cited by this paper
• Verification of protein structures: Patterns of nonbonded atomic interactions

  1993cited by this paper
• Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.

  1992cited by this paper
• Human cytochrome P-450 enzymes.

  1992cited by this paper
• A method to identify protein sequences that fold into a known three-dimensional structure.

  1991cited by this paper
• Bufuralol, dextromethorphan, and debrisoquine as prototype substrates for human P450IID6.

  1991cited by this paper
• Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine.

  1988cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Metabolism of debrisoquine sulfate. Identification of some urinary metabolites in rat and man.

  1975cited by this paper
• TREATMENT OF HYPERTENSION WITH DEBRISOQUIN SULFATE (DECLINAX).

  1965cited by this paper
• TREATMENT OF HYPERTENSION WITH DEBRISOQUIN SULFATE (DECLINAX).

  1965cited by this paper

• Elucidating the Binding and Metabolic Interactions of Sunitinib and Sorafenib with CYP2U1 and CYP2D6

  2026cites this paper
• Characterization of the Orphan Cytochrome P450 CYP135B1 from Mycobacterium tuberculosis: Involvement in Metabolism but Not in the Antibacterial Activity of the Antitubercular Drug SQ109.

  2025cites this paper
• Tuning architectural organization of eukaryotic P450 system to boost bioproduction in Escherichia coli

  2024cites this paper
• Key regulators in the architecture of substrate access/egress channels in mammalian cytochromes P450 governing flexibility in substrate oxyfunctionalization.

  2023cites this paper
• Functional expression and regulation of eukaryotic cytochrome P450 enzymes in surrogate microbial cell factories

  2022cites this paper
• Human Orphan Cytochrome P450 2U1 Catalyzes the ω-Hydroxylation of Leukotriene B4

  2022cites this paper
• GRID1/GluD1 homozygous variants linked to intellectual disability and spastic paraplegia impair mGlu1/5 receptor signaling and excitatory synapses

  2022cites this paper
• Structural insights into understudied human cytochrome P450 enzymes.

  2021cites this paper
• The CYP2R1 Enzyme: Structure, Function, Enzymatic Properties and Genetic Polymorphism.

  2021cites this paper
• Implication of folate deficiency in CYP2U1 loss of function

  2021cites this paper
• Functional expression of eukaryotic cytochrome P450s in yeast

  2020cites this paper
• Engineering indel and substitution variants of diverse and ancient enzymes using Graphical Representation of Ancestral Sequence Predictions (GRASP)

  2019cites this paper
• CYP2U1 activity is altered by missense mutations in hereditary spastic paraplegia 56

  2018influential citation
• Recombinant production of eukaryotic cytochrome P450s in microbial cell factories

  2018cites this paper
• Spectral and 3D model studies of the interaction of orphan human cytochrome P450 2U1 with substrates and ligands.

  2017cites this paper
• Cytochrome P450 2U1, a very peculiar member of the human P450s family

  2017cites this paper
• Membrane-bound human orphan cytochrome P450 2U1: Sequence singularities, construction of a full 3D model, and substrate docking.

  2017cites this paper
• Regulation of ABCB1 expression and activity in porcine brain endothelial cells

  2016cites this paper
• Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs

  2016cites this paper
• Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

  2016cites this paper